Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways. [electronic resource]
- Journal of translational medicine 04 2019
- 122 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't